JP2020524151A5 - - Google Patents

Download PDF

Info

Publication number
JP2020524151A5
JP2020524151A5 JP2019569956A JP2019569956A JP2020524151A5 JP 2020524151 A5 JP2020524151 A5 JP 2020524151A5 JP 2019569956 A JP2019569956 A JP 2019569956A JP 2019569956 A JP2019569956 A JP 2019569956A JP 2020524151 A5 JP2020524151 A5 JP 2020524151A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
extract
fraction
cannabinoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2019569956A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020524151A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2018/050604 external-priority patent/WO2018232448A1/en
Publication of JP2020524151A publication Critical patent/JP2020524151A/ja
Publication of JP2020524151A5 publication Critical patent/JP2020524151A5/ja
Ceased legal-status Critical Current

Links

JP2019569956A 2017-06-19 2018-06-19 睡眠障害組成物及びその治療 Ceased JP2020524151A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2017902338 2017-06-19
AU2017902338A AU2017902338A0 (en) 2017-06-19 Sleep Disorder Composition and Treatment Thereof
AU2017904818 2017-11-29
AU2017904818A AU2017904818A0 (en) 2017-11-29 Sleep Disorder Compositions and Treatments Thereof
PCT/AU2018/050604 WO2018232448A1 (en) 2017-06-19 2018-06-19 COMPOSITION AGAINST SLEEP APNEA AND RELATED TREATMENTS

Publications (2)

Publication Number Publication Date
JP2020524151A JP2020524151A (ja) 2020-08-13
JP2020524151A5 true JP2020524151A5 (enExample) 2021-07-26

Family

ID=62947713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019569956A Ceased JP2020524151A (ja) 2017-06-19 2018-06-19 睡眠障害組成物及びその治療

Country Status (16)

Country Link
US (2) US20210145910A1 (enExample)
EP (1) EP3641754A4 (enExample)
JP (1) JP2020524151A (enExample)
KR (1) KR20200104278A (enExample)
CN (1) CN110944632A (enExample)
AU (2) AU2018100837B4 (enExample)
BR (1) BR112019026877A2 (enExample)
CA (1) CA3065563C (enExample)
CL (1) CL2019003635A1 (enExample)
CO (1) CO2019013887A2 (enExample)
IL (1) IL271503A (enExample)
MX (1) MX387442B (enExample)
NZ (1) NZ759963A (enExample)
PE (1) PE20201163A1 (enExample)
SG (1) SG11201912380XA (enExample)
WO (1) WO2018232448A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3031810A1 (en) 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
CA3027876A1 (en) * 2018-12-18 2020-06-18 Tetra Bio-Pharma Cannabis compositions and methods
NL2022616B1 (en) 2019-02-21 2020-09-18 Patrick Alexander Unger Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia
US10946054B1 (en) * 2019-10-08 2021-03-16 Jenny's Rose, LLC Therapeutic cannabis extracts
WO2021178579A1 (en) * 2020-03-03 2021-09-10 Alte Verde Llc Cannabis treatment of insomnia, pain, and skin conditions
EP4117641A1 (en) * 2020-03-09 2023-01-18 This Works Products Limited Compositions comprising functional fragrances and cannabis-derived compounds
CN112057894A (zh) * 2020-09-08 2020-12-11 云南工麻生物科技有限公司 一种提取大麻二酚的方法
CA3200651A1 (en) * 2020-12-04 2022-06-09 Joel Ernest George HARDY Antiinflammatory compositions comprising cannabidiol, delta-9- tetrahydrocannabinol and linalool
CN113143995A (zh) * 2021-01-21 2021-07-23 龙麻(上海)医药研发有限责任公司 一种大麻提取物舌下片及其制备工艺和应用
CN112999218A (zh) * 2021-01-21 2021-06-22 龙麻(上海)医药研发有限责任公司 一种具有镇静助眠功效的组合物及用途
MX2023008876A (es) * 2021-01-28 2023-09-12 Zynerba Pharmaceuticals Inc Tratamiento de la apnea del sueño con cannabidiol (cbd).
CN112791151B (zh) * 2021-02-20 2022-04-01 山东新稀宝股份有限公司 一种具有改善睡眠功能的组合物及应用
DK181329B1 (en) 2021-05-04 2023-08-16 Cs Medica As Nasal sleep spray composition, method for its provision, and receptacle and kit comprising said composition
US20220401407A1 (en) * 2021-06-09 2022-12-22 Demetrix, Inc. Regulation of the sleep/wake cycle using cannabinoid compounds
CA3238591A1 (en) * 2022-01-27 2023-08-03 Paul MUCHOWSKI A cannabidiol (cbd) and terpene formulation that increases restorative sleep in humans

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
DE10051427C1 (de) * 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
JP4657716B2 (ja) 2002-08-14 2011-03-23 ジーダブリュー・ファーマ・リミテッド 植物材料からの薬学的に活性な成分の抽出の改良
GB2418612A (en) 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
GB201117956D0 (en) 2011-10-18 2011-11-30 Otsuka Pharma Co Ltd Phytocannabinoids for use in the treatment of breast cancer
EP2844243B8 (en) 2012-05-03 2019-12-18 Echo Pharmaceuticals B.V. Method for preparing a cannabis plant isolate comprising delta-9-tetrahydrocannabinol
CA2895805A1 (en) 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
US9763991B2 (en) * 2013-06-13 2017-09-19 Cannabis Science International Holding B.V. Composition for the treatment of neurobehavioral disorders
CN103355391A (zh) * 2013-08-13 2013-10-23 汕头大学医学院第一附属医院 一种五味健脑益智饼及其制备方法
US10265292B2 (en) 2013-09-18 2019-04-23 The Werc Shop, LLC Terpene-based compositions, processes methodologies
DK3062606T3 (da) 2013-10-29 2019-06-24 Biotech Inst Llc Forædling, fremstilling, forarbejdning og anvendelse af speciel cannabis
KR20160094950A (ko) 2013-10-31 2016-08-10 풀 스펙트럼 래버러토리즈, 리미티드 테르펜 및 칸나비노이드 제제
CN105010577A (zh) 2014-04-17 2015-11-04 天津市麦地那食品贸易有限公司 一种火麻、橄榄、葡萄籽、葵花籽调和油
CA2952934A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
AU2015308546A1 (en) 2014-08-25 2017-04-13 Clk Consult V/ Carsten Leonhard Knudsen Device with compositions for delivery to the lungs, the oral mucosa and the brain
US9730911B2 (en) * 2014-10-21 2017-08-15 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
HK1244710A1 (zh) 2014-12-12 2018-08-17 Ojai Energetics Pbc 微胶囊化大麻素组合物
MX386351B (es) * 2015-01-31 2025-03-18 Constance Therapeutics Inc Métodos para la preparación de extractos y composiciones de aceite de cannabis.
MX2017010872A (es) 2015-02-27 2018-05-07 Ebbu Llc Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.
CA2986268C (en) * 2015-05-28 2024-01-02 Insys Development Company, Inc. Stable cannabinoid formulations
IL246790A0 (en) * 2016-07-14 2016-09-29 Friedman Doron Self-dissolving compounds of cannabinoids
MX386086B (es) 2016-08-03 2025-03-18 Zelda Therapeutics Operations Pty Ltd Composicion de cannabis
CA3031810A1 (en) 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition
US9649349B1 (en) * 2017-01-19 2017-05-16 Metamorphic Alchemy & Distillations, Inc. System and method for producing a terpene-enhanced cannibinoid concentrate
US20200179269A1 (en) * 2017-03-20 2020-06-11 Kanabo Research Ltd. Vaporizable compositions comprising cannabinol
US20180352848A1 (en) * 2017-06-07 2018-12-13 NC3 Systems Smokable cannabis-based product with reduced psychoactive effects
EP3681525A4 (en) 2017-09-15 2020-09-02 Zelda Therapeutics Operations Pty Ltd COMPOSITION AND METHOD OF PROCESSING AUTISM
EP3745884A1 (en) * 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
AU2018100924A4 (en) 2018-07-03 2018-08-09 Zelira Therapeutics Operations Pty Ltd Composition and method for treating pain
BR112022025302A2 (pt) 2020-06-12 2023-02-28 Zelira Therapeutics Operations Pty Ltd Composição e método para tratamento da dor crônica
WO2022094671A1 (en) 2020-11-06 2022-05-12 Zelira Therapeutics Operations Pty Ltd Cannabinoid encapsulation technology

Similar Documents

Publication Publication Date Title
JP2020524151A5 (enExample)
JP2019523283A5 (enExample)
JP2019526541A5 (enExample)
MX387442B (es) Composiciones y tratamientos para el trastorno del sueño
FI3743053T3 (fi) Kannabinoidien käyttö epilepsian hoidossa
AU2021201949A1 (en) Device with compositions for delivery to the lungs, the oral mucosa and the brain
JP2019510060A5 (enExample)
US11318093B2 (en) Dental topical anesthetic gel
CO2019001895A2 (es) Formulación novedosa para administración por vía oral
IL275704B2 (en) Oral pharmaceutical formulation comprising cannabinoids and poloxamer
JP2009539961A5 (enExample)
Allais et al. Premenstrual syndrome and migraine
JP2016523862A5 (enExample)
PE20200677A1 (es) Composicion de cannabis
TW200718418A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
GB201111261D0 (en) Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
US20230087359A1 (en) Cannabinoid compositions and methods of use thereof
FI3504187T3 (fi) Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten
CN104127496A (zh) 一种治疗鼻炎、鼻窦炎的药物
MX386620B (es) Composicion de cannabis
US20140343136A1 (en) Phytocannabinoids for use in the treatment of intestinal inflammatory diseases
US20230125099A1 (en) Oronasal cbd formulations and uses thereof
US20210236687A1 (en) Cannabinoid-based oral hemostatic compositions
US20210369802A1 (en) Cannabis plant formulations and methods of delivery
GRAUL Marijuana and Glaucoma